Can patients with relapsed, previously untreated, stage I epithelial ovarian cancer be successfully treated with salvage therapy?

Journal of Clinical Oncology

Volumn 21, Issue 16, 2003, Pages 3113-3118

  Kolomainen, Desiree F ^a   A'Hern, Roger ^a   Coxon, Fareeda Y ^a   Fisher, Cyril ^a   King, D Michael ^a   Blake, Peter R ^a   Barton, Desmond P J ^a   Shepherd, John H ^a   Kaye, Stanley B ^a   Gore, Martin E ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLATINUM DERIVATIVE; PLATINUM COMPLEX;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY; ADJUVANT CHEMOTHERAPY; ADULT; AGED; DISEASE FREE SURVIVAL; MIDDLE AGED; OVARY TUMOR; SURVIVAL; TUMOR RECURRENCE;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGANOPLATINUM COMPOUNDS; OVARIAN NEOPLASMS; PROGNOSIS; SALVAGE THERAPY; SURVIVAL ANALYSIS;

EID: 0041912752     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.06.119     Document Type: Article

References (12)

1. Greenlee RT, Murray T, Bolden S, et al: Cancer statistics, 2000. CA Cancer J Clin 50:7-33, 2000
2. Annual report on the results of treatment in gynecological cancer, vol 23: Statements of results obtained in patients treated in 1990-1992. J Epidemiol Biostat 3:1-135, 1998
3. Fiedlander M: Prognostic factors, in Sharp F, Blackett T, Berek J, et al (eds): Ovarian Cancer (ed 5, part III). Oxford, UK, Isis Medical Media Ltd, 2000, pp 199-215
4. Ahmed FY, Wiltshaw E, A'Hern RP, et al: Natural history and prognosis of untreated stage I epithelial ovarian cancer. J Clin Oncol 14:2968-2975, 1996
5. Vergote I, De Brabanter J, Fyles A, et al: Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 357:176-182, 2001
6. World Health Organization: WHO Handbook for Reporting Results of Cancer Treatment. Offset publication. Geneva, Switzerland, World Health Organization, 1979
7. Taylor AE, Wiltshaw E, Gore ME, et al: Long-term follow-up of the first randomized study of cisplatin versus carboplatin for advanced epithelial ovarian cancer. J Clin Oncol 12:2066-2070, 1994
8. Gore M, Mainwaring P, A'Hern R, et al: Randomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer. J Clin Oncol 16:2426-2434, 1998
9. International Collaborative Ovarian Neoplasm Trial 1: A randomized trial of chemotherapy in women with early-stage ovarian cancer. J Natl Cancer Inst 95:125-132, 2003
10. Trimbos JB, Vertgote I, Bolis G, et al: Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organization for Research and Treatment of Cancer Adjuvant Chemotherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 95:113-124, 2003
11. International Collaborative Ovarian Neoplasm Trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm Trial: Two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 95:105-112, 2003
12. Young RC: Early-stage ovarian cancer: To treat or not to treat. J Natl Cancer Inst 95:94-95, 2003